| 4 weeks |
| |
Single treatment |
Combined treatment |
p-value |
| Evaluation |
n |
% |
n |
% |
|
| Worsened |
1 |
9.1 |
2 |
10.5 |
0.8064 |
| No change |
2 |
18.2 |
6 |
31.6 |
| Slightly improved |
6 |
54.5 |
9 |
47.4 |
| Moderately improved |
1 |
9.1 |
2 |
10.5 |
| Markedly improved |
1 |
9.1 |
0 |
0 |
| Total |
11 |
100 |
19 |
100 |
- |
| 8 weeks |
| Worsened |
0 |
0 |
1 |
5.9 |
0.8539 |
| No change |
0 |
0 |
2 |
11.8 |
| Slightly improved |
5 |
45.5 |
6 |
35.3 |
| Moderately improved |
5 |
45.5 |
6 |
35.3 |
| Markedly improved |
1 |
9.1 |
2 |
11.8 |
| Total |
11 |
100 |
17 |
100 |
- |
| 12 weeks |
| Worsened |
0 |
0 |
2 |
11.8 |
0.6644 |
| No change |
1 |
9.1 |
0 |
0 |
| Slightly improved |
2 |
18.2 |
3 |
17.6 |
| Moderately improved |
3 |
27.3 |
6 |
35.3 |
| Markedly improved |
5 |
45.5 |
6 |
35.3 |
| Total |
11 |
100 |
17 |
100 |
- |
|
